- Investing Ideas
- /
- U.S. Healthcare Large Cap High Growth Potential
U.S. Healthcare Large Cap High Growth Potential
Results
9
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
9 companies
DexCom
Market Cap: US$27.6b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$70.33
7D
5.6%
1Y
-4.2%
Hims & Hers Health
Market Cap: US$11.0b
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
HIMS
US$48.78
7D
-2.0%
1Y
124.5%
Solventum
Market Cap: US$12.4b
A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
SOLV
US$71.44
7D
-1.0%
1Y
-2.4%
Insulet
Market Cap: US$22.6b
Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
PODD
US$320.91
7D
0.7%
1Y
37.4%
Baxter International
Market Cap: US$11.8b
Through its subsidiaries, provides a portfolio of healthcare products in the United States.
BAX
US$23.02
7D
-0.3%
1Y
-36.0%
Veeva Systems
Market Cap: US$48.0b
Provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
VEEV
US$293.02
7D
3.3%
1Y
38.1%
Humana
Market Cap: US$35.0b
Provides medical and specialty insurance products in the United States.
HUM
US$290.65
7D
5.7%
1Y
11.5%
Boston Scientific
Market Cap: US$149.8b
Develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
BSX
US$101.11
7D
1.9%
1Y
19.3%
Stryker
Market Cap: US$146.0b
Operates as a medical technology company.
SYK
US$381.79
7D
2.0%
1Y
8.2%